Cargando…
Real-World Outcomes of CDK4/6 Inhibitors Treatment in Metastatic Breast Cancer in Romania
The introduction in clinical practice of selective cyclin-dependent kinase (CDK) 4/6 inhibitors improves the outcome of patients with hormone receptor (HR)-positive human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer (mBC). In Romania, the three available CDK 4/6 inhibi...
Autores principales: | Miron, Andreea-Iuliana, Anghel, Alexandra-Valentina, Barnonschi, Andrei-Alexandru, Mitre, Ruxandra, Liscu, Horia-Dan, Găinariu, Estera, Pătru, Raluca, Coniac, Simona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10252356/ https://www.ncbi.nlm.nih.gov/pubmed/37296790 http://dx.doi.org/10.3390/diagnostics13111938 |
Ejemplares similares
-
The Conditioning of Adjuvant Chemotherapy for Stage II and III Rectal Cancer Determined by Postoperative Pathological Characteristics in Romania
por: Liscu, Horia-Dan, et al.
Publicado: (2023) -
Challenges and Limitations of Endocrine Toxicity Evaluation in Non-Small Cell Lung Cancer Patients Treated with Immunotherapy—Retrospective Study from a Tertiary-Level Hospital in Romania
por: Coniac, Simona, et al.
Publicado: (2023) -
Correlations between Demographic, Clinical, and Paraclinical Variables and Outcomes in Patients with KRAS-Mutant or KRAS Wild-Type Metastatic Colorectal Cancer—A Retrospective Study from a Tertiary-Level Center in Romania
por: Pîrvu, Edvina Elena, et al.
Publicado: (2023) -
Infection with Acinetobacter baumannii in an intensive care unit in the Western part of Romania
por: Lăzureanu, Voichița, et al.
Publicado: (2016) -
The Burden of Fungal Diseases in Romania
por: Mareș, Mihai, et al.
Publicado: (2018)